10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $526,350 | +36.6% | 12,760 | +84.9% | 0.00% | – |
| Q2 2023 | $385,296 | -2.1% | 6,900 | -2.2% | 0.00% | – |
| Q1 2023 | $393,710 | -14.8% | 7,057 | -44.4% | 0.00% | – |
| Q4 2022 | $462,314 | +22.3% | 12,687 | -4.4% | 0.00% | – |
| Q3 2022 | $378,000 | -46.9% | 13,269 | -15.6% | 0.00% | – |
| Q2 2022 | $712,000 | -32.5% | 15,730 | +13.5% | 0.00% | -100.0% |
| Q1 2022 | $1,055,000 | -53.2% | 13,864 | -8.4% | 0.00% | 0.0% |
| Q4 2021 | $2,254,000 | +45.8% | 15,131 | +42.5% | 0.00% | 0.0% |
| Q3 2021 | $1,546,000 | +31.6% | 10,621 | +77.1% | 0.00% | 0.0% |
| Q2 2021 | $1,175,000 | +66.9% | 5,998 | +54.1% | 0.00% | – |
| Q1 2021 | $704,000 | +57.8% | 3,892 | +23.5% | 0.00% | – |
| Q4 2020 | $446,000 | +88.2% | 3,152 | +66.2% | 0.00% | – |
| Q3 2020 | $237,000 | – | 1,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |